Autonomic Peripheral Neuropathy

Neurologic Clinics

Volumn 25, Issue 1, 2007, Pages 277-301

  Freeman, Roy ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACRYLAMIDE; AMIODARONE; CALCIUM CHANNEL; CISPLATIN; COLLAPSIN RESPONSE MEDIATOR PROTEIN; CYTARABINE; DOXORUBICIN; GOLD; HEAVY METAL; HU ANTIBODY; MARINE TOXIN; NICOTINIC RECEPTOR; ORGANIC SOLVENT; PACLITAXEL; PENTAMIDINE; PERHEXILINE MALEATE; PODOPHYLLIN; VACOR; VINCRISTINE;

AMYLOIDOSIS; AUTONOMIC NEUROPATHY; BOTULISM; CARDIOVASCULAR DISEASE; CHAGAS DISEASE; CLINICAL FEATURE; DIABETES MELLITUS; DIABETIC NEUROPATHY; DIPHTHERIA; DISEASE ASSOCIATION; FAMILIAL AMYLOID POLYNEUROPATHY; GASTROINTESTINAL DISEASE; GUILLAIN BARRE SYNDROME; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOLOGY; INFECTION; LEPROSY; PARANEOPLASTIC SYNDROME; PATHOGENESIS; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; REVIEW; SWEATING; THERMOREGULATION; UROGENITAL TRACT DISEASE;

AMYLOID NEUROPATHIES; AUTONOMIC NERVOUS SYSTEM DISEASES; GUILLAIN-BARRE SYNDROME; HEREDITARY SENSORY AND AUTONOMIC NEUROPATHIES; HUMANS; PERIPHERAL NERVOUS SYSTEM DISEASES;

EID: 33847148005     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ncl.2007.01.001     Document Type: Review

References (212)

1. Freeman R. Autonomic peripheral neuropathy. Lancet 365 9466 (2005) 1259-1270
2. Hilsted J., and Low P.A. Diabetic autonomic neuropathy. In: Low P.A. (Ed). Clinical autonomic disorders (1997), Lipincott-Raven, Philadelphia 487-508
3. Freeman R. The peripheral nervous system and diabetes. In: Kahn C.R., Weir G.C., and King G.L. (Eds). Joslin's diabetes mellitus (2004), Lippincott Williams & Wilkins, Philadelphia 951-968
4. Vinik A.I., Freeman R., and Erbas T. Diabetic autonomic neuropathy. Semin Neurol 23 4 (2003) 365-372
5. Vinik A.I., Maser R.E., Mitchell B.D., et al. Diabetic autonomic neuropathy. Diabetes Care 26 5 (2003) 1553-1579
6. Lloyd-Mostyn R.H., and Watkins P.J. Defective innervation of heart in diabetic autonomic neuropathy. BMJ 3 (1975) 15-17
7. Bennett T., Hosking D.J., and Hampton J.R. Cardiovascular control in diabetes mellitus. BMJ 2 (1975) 585-587
8. Ewing D.J., Campbell I.W., and Clarke B.F. Heart rate changes in diabetes mellitus. Lancet 1 (1981) 183-186
9. Low P.A., Walsh J.C., Huang C.Y., et al. The sympathetic nervous system in diabetic neuropathy: a clinical and pathological study. Brain 98 (1975) 341-356
10. Ewing D.J., Campbell I.W., and Clarke B.F. The natural history of diabetic autonomic neuropathy. Q J Med 49 (1980) 95-108
11. O'Brien I.A., McFadden J.P., and Corrall R.J. The influence of autonomic neuropathy on mortality in insulin-dependent diabetes. Q J Med 79 (1991) 495-502
12. Navarro X., Kennedy W.R., Loewenson R.B., et al. Influence of pancreas transplantation on cardiorespiratory reflexes, nerve conduction, and mortality in diabetes mellitus. Diabetes 39 (1990) 802-806
13. Rathmann W., Ziegler D., Jahnke M., et al. Mortality in diabetic patients with cardiovascular autonomic neuropathy. Diabet Med 10 9 (1993) 820-824
14. Sampson M.J., Wilson S., Karagiannis P., et al. Progression of diabetic autonomic neuropathy over a decade in insulin-dependent diabetics. Q J Med 75 (1990) 635-646
15. Chen H.S., Hwu C.M., Kuo B.I., et al. Abnormal cardiovascular reflex tests are predictors of mortality in type 2 diabetes mellitus. Diabet Med 18 4 (2001) 268-273
16. Gerritsen J., Dekker J.M., TenVoorde B.J., et al. Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease: the Hoorn Study. Diabetes Care 24 10 (2001) 1793-1798
17. Maser R.E., Pfeifer M.A., Dorman J.S., et al. Diabetic autonomic neuropathy and cardiovascular risk: Pittsburgh Epidemiology of Diabetes Complications Study III. Arch Intern Med 150 (1990) 1218-1222
18. Maser R.E., Mitchell B.D., Vinik A.I., et al. The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. Diabetes Care 26 6 (2003) 1895-1901
19. Frimodt-Moller C., and Mortensen S. Treatment of diabetic cystopathy. Ann Intern Med 92 (1980) 327-328
20. Ellenberg M. Development of urinary bladder dysfunction in diabetes mellitus. Ann Intern Med 92 (1980) 321-323
21. Ioanid C.P., and Noica N. Incidence and diagnostic aspects of the bladder disorders in diabetics. Eur Urol 7 (1981) 211-214
22. Kaplan S.A., and Blaivas J.G. Diabetic cystopathy. [review]. J Diabet Complications 2 3 (1988) 133-139
23. Kaplan S.A., Te A.E., and Blaivas J.G. Urodynamic findings in patients with diabetic cystopathy. [see comments]. J Urol 153 2 (1995) 342-344
24. McCulloch D.K., Campbell I.W., Wu F.C., et al. The prevalence of diabetic impotence. Diabetologia 18 (1980) 279-283
25. Ellenberg M. Impotence in diabetes: the neurologic factor. Ann Intern Med 75 2 (1971) 213-219
26. Kaiser F.E., and Korenman S.G. Impotence in diabetic men. Am J Med 85 Suppl 5A (1988) 147-152
27. Hakim L.S., and Goldstein I. Diabetic sexual dysfunction. [review]. Endocrinol Metab Clin North Am 25 2 (1996) 379-400
28. Bacon C.G., Hu F.B., Giovannucci E., et al. Association of type and duration of diabetes with erectile dysfunction in a large cohort of men. Diabetes Care 25 8 (2002) 1458-1463
29. de Tejada I.S., Goldstein I., Azadzoi K., et al. Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N Engl J Med 320 (1989) 1025-1030
30. Ellenberg M. Sexual function in diabetic patients. Ann Intern Med 92 (1980) 331-333
31. Enzlin P., Mathieu C., Van den B.A., et al. Sexual dysfunction in women with type 1 diabetes: a controlled study. Diabetes Care 25 4 (2002) 672-677
32. Wegener M., Borsch G., Schaffstein J., et al. Gastrointestinal transit disorders in patients with insulin-treated diabetes mellitus. Dig Dis 8 (1990) 23-36
33. Horowitz M., Harding P.E., Maddox A.F., et al. Gastric and oesophageal emptying in patients with Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 32 (1989) 151-159
34. Enck P., and Frieling T. Pathophysiology of diabetic gastroparesis. Diabetes 46 Suppl 2 (1997) S77-S81
35. Kong M.F., Horowitz M., Jones K.L., et al. Natural history of diabetic gastroparesis. Diabetes Care 22 3 (1999) 503-507
36. Jones K.L., Russo A., Stevens J.E., et al. Predictors of delayed gastric emptying in diabetes. Diabetes Care 24 7 (2001) 1264-1269
37. Hebbard G.S., Samsom M., Sun W.M., et al. Hyperglycemia affects proximal gastric motor and sensory function during small intestinal triglyceride infusion. Am J Physiol 271 5 Pt 1 (1996) G814-G819
38. Rayner C.K., Samsom M., Jones K.L., et al. Relationships of upper gastrointestinal motor and sensory function with glycemic control. Diabetes Care 24 2 (2001) 371-381
39. Battle W.M., Snape Jr. W.J., Alavi A., et al. Colonic dysfunction in diabetes mellitus. Gastroenterology 79 (1980) 1217-1221
40. Feldman M., and Schiller L.R. Disorders of gastrointestinal motility associated with diabetes mellitus. Ann Intern Med 98 (1983) 378-384
41. Maleki D., Locke III G.R., Camilleri M., et al. Gastrointestinal tract symptoms among persons with diabetes mellitus in the community. Arch Intern Med 160 18 (2000) 2808-2816
42. Lysy J., Israeli E., and Goldin E. The prevalence of chronic diarrhea among diabetic patients. Am J Gastroenterol 94 8 (1999) 2165-2170
43. Schiller L.R., Santa Ana C.A., Schmulen A.C., et al. Pathogenesis of fecal incontinence in diabetes mellitus: evidence for internal-anal-sphincter dysfunction. N Engl J Med 307 (1982) 1666-1671
44. Fedorak R.N., Field M., and Chang E.B. Treatment of diabetic diarrhea with clonidine. Ann Intern Med 102 (1985) 197-199
45. Fealey R.D., Low P.A., and Thomas J.E. Thermoregulatory sweating abnormalities in diabetes mellitus. Mayo Clin Proc 64 6 (1989) 617-628
46. Shaw J.E., Parker R., Hollis S., et al. Gustatory sweating in diabetes mellitus. Diabet Med 13 12 (1996) 1033-1037
47. Singleton J.R., Smith A.G., and Bromberg M.B. Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy. Diabetes Care 24 8 (2001) 1448-1453
48. Smith A.G., Ramachandran P., Tripp S., et al. Epidermal nerve innervation in impaired glucose tolerance and diabetes-associated neuropathy. Neurology 57 9 (2001) 1701-1704
49. Smith A.G., Russell J., Feldman E.L., et al. Lifestyle intervention for pre-diabetic neuropathy. Diabetes Care 29 6 (2006) 1294-1299
50. Sumner C.J., Sheth S., Griffin J.W., et al. The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology 60 1 (2003) 108-111
51. Novella S.P., Inzucchi S.E., and Goldstein J.M. The frequency of undiagnosed diabetes and impaired glucose tolerance in patients with idiopathic sensory neuropathy. Muscle Nerve 24 9 (2001) 1229-1231
52. Falk R.H., Comenzo R.L., and Skinner M. The systemic amyloidoses. N Engl J Med 337 13 (1997) 898-909
53. Adams D. Hereditary and acquired amyloid neuropathies. J Neurol 248 8 (2001) 647-657
54. Kyle R.A., and Dyck P.J. Amyloidosis and neuropathy. In: Dyck P.J., Thomas P.K., Griffin J.W., et al. (Eds). Peripheral neuropathy (1993), WB Saunders, Philadelphia 1294-1309
55. Kernohan J.W., and Woltman H.W. Amyloid neuritis. Arch Neurol Psychiatry 27 (1967) 132-140
56. DeNavasguez S., and Treble H.A. A case of generalized amyloid disease with involvement of nerves. Brain 61 (1938) 116-128
57. Sullivan J.F., Twitchel T., Gherardi G.J., et al. Amyloid polyneuropathy. Neurology 5 (1955) 847-855
58. Rajkumar S.V., Gertz M.A., and Kyle R.A. Prognosis of patients with primary systemic amyloidosis who present with dominant neuropathy. Am J Med 104 3 (1998) 232-237
59. Ando Y., Nyhlin N., Suhr O., et al. Oxidative stress is found in amyloid deposits in systemic amyloidosis. Biochem Biophys Res Commun 232 2 (1997) 497-502
60. Ando Y., Suhr O., and El Salhy M. Oxidative stress and amyloidosis. Histol Histopathol 13 3 (1998) 845-850
61. Simmons Z., Blaivas M., Aguilera A.J., et al. Low diagnostic yield of sural nerve biopsy in patients with peripheral neuropathy and primary amyloidosis. J Neurol Sci 120 1 (1993) 60-63
62. Falk R.H., and Skinner M. The systemic amyloidoses: an overview. Adv Intern Med 45 (2000) 107-137
63. Kyle R.A., and Gertz M.A. Systemic amyloidosis. Crit Rev Oncol Hematol 10 1 (1990) 49-87
64. Skinner M., Anderson J., Simms R., et al. Treatment of 100 patients with primary amyloidosis: a randomized trial of melphalan, prednisone, and colchicine versus colchicine only. Am J Med 100 3 (1996) 290-298
65. Kyle R.A., Gertz M.A., Greipp P.R., et al. A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine. N Engl J Med 336 17 (1997) 1202-1207
66. Gertz M.A., Lacy M.Q., Dispenzieri A., et al. Stem cell transplantation for the management of primary systemic amyloidosis. Am J Med 113 7 (2002) 549-555
67. Andrade C. A peculiar form of peripheral neuropathy: familiar atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain 75 (1952) 408-426
68. Saraiva M.J.M., Costa P.P., and Goodman D.S. Biochemical marker in familial amyloidotic polyneuropathy, Portuguese type: family studies of transthyretin (prealbumin)-methionine-30 variant. J Clin Invest 76 (1985) 2171-2177
69. Hund E., Linke R.P., Willig F., et al. Transthyretin-associated neuropathic amyloidosis: pathogenesis and treatment. Neurology 56 4 (2001) 431-435
70. Rukavina J.G., Block W.D., Jackson C.E., et al. Primary systemic amyloidosis: a review and an experimental genetic and clinical study of 29 cases with particular emphasis on the familial form. Medicine 35 (1956) 239-334
71. Mahloudji M., Teasdall R.D., Adamkiewicz J.J., et al. The genetic amyloidoses with particular reference to hereditary neuropathic amyloidosis, type II (Indiana or Rukavina type). Medicine (Baltimore) 48 1 (1969) 1-37
72. Ando Y., Nakamura M., and Araki S. Transthyretin-related familial amyloidotic polyneuropathy. Arch Neurol 62 7 (2005) 1057-1062
73. Misu K., Hattori N., Nagamatsu M., et al. Late-onset familial amyloid polyneuropathy type I (transthyretin Met30-associated familial amyloid polyneuropathy) unrelated to endemic focus in Japan: clinicopathological and genetic features. Brain 122 Pt 10 (1999) 1951-1962
74. Lachmann H.J., Booth D.R., Booth S.E., et al. Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis. N Engl J Med 346 23 (2002) 1786-1791
75. Holmgren G., Ericzon B.G., Groth C.G., et al. Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet 341 8853 (1993) 1113-1116
76. Adams D., Samuel D., Goulon-Goeau C., et al. The course and prognostic factors of familial amyloid polyneuropathy after liver transplantation. Brain 123 Pt 7 (2000) 1495-1504
77. Bergethon P.R., Sabin T.D., Lewis D., et al. Improvement in the polyneuropathy associated with familial amyloid polyneuropathy after liver transplantation. Neurology 47 4 (1996) 944-951
78. Pomfret E.A., Lewis W.D., Jenkins R.L., et al. Effect of orthotopic liver transplantation on the progression of familial amyloidotic polyneuropathy. Transplantation 65 7 (1998) 918-925
79. Delahaye N., Rouzet F., Sarda L., et al. Impact of liver transplantation on cardiac autonomic denervation in familial amyloid polyneuropathy. Medicine (Baltimore) 85 4 (2006) 229-238
80. Hammarstrom P., Wiseman R.L., Powers E.T., et al. Prevention of transthyretin amyloid disease by changing protein misfolding energetics. Science 299 5607 (2003) 713-716
81. Tuck R.R., and McLeod J.G. Autonomic dysfunction in Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 44 (1981) 983-990
82. Zochodne D.W. Autonomic involvement in Guillain-Barré syndrome: a review. Muscle Nerve 17 10 (1994) 1145-1155
83. Cortelli P., Contin M., Lugaresi A., et al. Severe dysautonomic onset of Guillain-Barré syndrome with good recovery: a clinical and autonomic follow-up study. Ital J Neurol Sci 11 (1990) 159-162
84. Feasby T.E., Gilbert J.J., Brown W.F., et al. An acute axonal form of Guillain-Barré polyneuropathy. Brain 109 (1986) 1115-1126
85. Winer J.B., and Hughes R.A.C. Identification of patients at risk of arrhythmia in the Guillain-Barré syndrome. Q J Med 257 (1988) 735-739
86. Ropper A.H., Wijdicks E.F.M., and Truax B.T. Guillain-Barré syndrome (1991), FA Davis, Philadelphia
87. Suarez G.A., Fealey R.D., Camilleri M., et al. Idiopathic autonomic neuropathy: clinical, neurophysiologic, and follow-up studies on 27 patients. Neurology 44 (1994) 1675-1682
88. Stewart P.M., and Hensley W.J. An acute attack of variegate porphyria complicated by severe autonomic neuropathy. Aust N Z J Med 11 (1981) 82-83
89. Young R.R., Asbury A.K., Corbett J.L., et al. Pure pan-dysautonomia with recovery. Brain 98 (1975) 613-636
90. Hart R.G., and Kanter M.C. Acute autonomic neuropathy: two cases and a clinical review. Arch Intern Med 150 (1990) 2373-2376
91. Yahr M.D., and Frontera A.T. Acute autonomic neuropathy: Its occurrence in infectious mononucleosis. Arch Neurol 32 (1975) 132-133
92. Fujii N., Tabira T., Shibasaki H., et al. Acute autonomic and sensory neuropathy associated with elevated Epstein-Barr virus antibody titre. [letter]. J Neurol Neurosurg Psychiatry 45 (1982) 656-657
93. Thomashefsky A.J., Horwitz S.J., and Feingold M.H. Acute autonomic neuropathy. Neurology 22 (1972) 251-255
94. Pavesi G., Gemignani F., Macaluso G.M., et al. Acute sensory and autonomic neuropathy: possible association with coxsackie B virus infection. J Neurol Neurosurg Psychiatry 55 7 (1992) 613-615
95. Summers Q., and Harris A. Autonomic neuropathy after rubella infection. Med J Aust 147 7 (1987) 353-355
96. Neville B.G., and Sladen G.E. Acute autonomic neuropathy following primary herpes simplex infection. J Neurol Neurosurg Psychiatry 47 (1984) 648-650
97. Fagius J., Westerberg C.E., and Olsson Y. Acute pandysautonomia and severe sensory deficit with poor recovery: a clinical, neurophysiological and pathological case study. J Neurol Neurosurg Psychiatry 46 8 (1983) 725-733
98. van Lieshout J.J., Wieling W., van Montfrans G.A., et al. Acute dysautonomia associated with Hodgkin's disease. J Neurol Neurosurg Psychiatry 49 (1986) 830-832 [Published erratum appears in J Neurol Neurosurg Psychiatry 1986;49(12):1461]
99. Hoyle C., Ewing D.J., and Parker A.C. Acute autonomic neuropathy in association with systemic lupus erythematosus. Ann Rheum Dis 44 (1985) 420-424
100. Arruda W.O., Teive H.A., Ramina R., et al. Autonomic neuropathy in systemic lupus erythematosus. J Neurol Neurosurg Psychiatry 52 4 (1989) 539-540
101. Heafield M.T., Gammage M.D., Nightingale S., et al. Idiopathic dysautonomia treated with intravenous gammaglobulin. Lancet 347 8993 (1996) 28-29
102. Smit A.A., Vermeulen M., Koelman J.H., et al. Unusual recovery from acute panautonomic neuropathy after immunoglobulin therapy. Mayo Clin Proc 72 4 (1997) 333-335
103. Wright R.A., Grant I.A., and Low P.A. Autonomic neuropathy associated with sicca complex. J Auton Nerv Syst 75 1 (1999) 70-76
104. Edmonds M.E., Jones T.C., Saunders W.A., et al. Autonomic neuropathy in rheumatoid arthritis. BMJ 2 (1979) 173-175
105. Lucchinetti C.F., Kimmel D.W., and Lennon V.A. Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies. Neurology 50 3 (1998) 652-657
106. Lennon V.A., Sas D.F., Busk M.F., et al. Enteric neuronal autoantibodies in pseudo-obstruction with small cell lung carcinoma. Gastroenterology 100 (1991) 137-142
107. Dalmau J., Graus F., Rosenblum M.K., et al. Anti-Hu-associated paraneoplastic encephalomyelitis/sensory neuronopathy: a clinical study of 71 patients. Medicine 71 (1992) 59-72
108. Camdessanche J.P., Antoine J.C., Honnorat J., et al. Paraneoplastic peripheral neuropathy associated with anti-Hu antibodies: a clinical and electrophysiological study of 20 patients. Brain 125 Pt 1 (2002) 166-175
109. Vernino S., and Lennon V.A. New Purkinje cell antibody (PCA-2): marker of lung cancer-related neurological autoimmunity. Ann Neurol 47 3 (2000) 297-305
110. Yu Z., Kryzer T.J., Griesmann G.E., et al. CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity. Ann Neurol 49 2 (2001) 146-154
111. Vernino S., Low P.A., Fealey R.D., et al. Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N Engl J Med 343 12 (2000) 847-855
112. Vernino S., Low P.A., and Lennon V.A. Experimental autoimmune autonomic neuropathy. J Neurophysiol 90 3 (2003) 2053-2059
113. Klein C.M., Vernino S., Lennon V.A., et al. The spectrum of autoimmune autonomic neuropathies. Ann Neurol 53 6 (2003) 752-758
114. Sandroni P., Vernino S., Klein C.M., et al. Idiopathic autonomic neuropathy: comparison of cases seropositive and seronegative for ganglionic acetylcholine receptor antibody. Arch Neurol 61 1 (2004) 44-48
115. Schroeder C., Vernino S., Birkenfeld A.L., et al. Plasma exchange for primary autoimmune autonomic failure. N Engl J Med 353 15 (2005) 1585-1590
116. Gibbons C.H., Vernino S.A., Kaufmann H., et al. L-DOPS therapy for refractory orthostatic hypotension in autoimmune autonomic neuropathy. Neurology 65 7 (2005) 1104-1106
117. Goldstein D.S., Holmes C., Dendi R., et al. Pandysautonomia associated with impaired ganglionic neurotransmission and circulating antibody to the neuronal nicotinic receptor. Clin Auton Res 12 4 (2002) 281-285
118. Hadjivassiliou M., Grunewald R.A., and Davies-Jones G.A. Gluten sensitivity as a neurological illness. J Neurol Neurosurg Psychiatry 72 5 (2002) 560-563
119. Chin R.L., Sander H.W., Brannagan T.H., et al. Celiac neuropathy. Neurology 60 10 (2003) 1581-1585
120. Cross A.H., and Golumbek P.T. Neurologic manifestations of celiac disease: proven, or just a gut feeling?. Neurology 60 10 (2003) 1566-1568
121. Hadjivassiliou M., Davies-Jones G.A., Sanders D.S., et al. Dietary treatment of gluten ataxia. J Neurol Neurosurg Psychiatry 74 9 (2003) 1221-1224
122. Gibbons C.H., and Freeman R. Autonomic neuropathy and coeliac disease. J Neurol Neurosurg Psychiatry 76 4 (2005) 579-581
123. Usai P., Usai S.P., Lai M., et al. Autonomic dysfunction and upper digestive functional disorders in untreated adult coeliac disease. Eur J Clin Invest 27 12 (1997) 1009-1015
124. Axelrod F.B., and Pearson J. Congenital sensory neuropathies: diagnostic distinction from familial dysautonomia. Am J Dis Child 138 10 (1984) 947-954
125. Dyck P.J. Neuronal atrophy and degeneration predominantly affecting peripheral sensory and autonomic neurons. In: Dyck P.J., Thomas P.K., Griffin J.W., et al. (Eds). Peripheral neuropathy (1993), WB Saunders, Philadelphia 1065-1093
126. Thomas P.K. Autonomic involvement in inherited neuropathies. Clin Auton Res 2 (1992) 51-56
127. Axelrod F.B. Hereditary sensory and autonomic neuropathies: familial dysautonomia and other HSANs. Clin Auton Res 12 Suppl 1 (2002) 12-14
128. Houlden H., Smith S., de Carvalho M., et al. Clinical and genetic characterization of families with triple A (Allgrove) syndrome. Brain 125 Pt 12 (2002) 2681-2690
129. Herbert P.N. Abetalipoproteinemia, hypobetalipoproteineima, and Tangier disease. In: Dyck P.J., Thomas P.K., Lambert E.H., et al. (Eds). Peripheral neuropathy (1984), WB Saunders, Philadelphia 1728-1744
130. Dyck P.J., Ellefson R.D., and Yao J.K. Adult-onset of Tangier disease: I. Morphometric and pathologic studies suggesting delayed degradation of neutral lipids after fiber degeneration. J Neuropathol Exp Neurol 37 (1978) 119-137
131. Low P.A., Dyck P.J., Okazaki H., et al. The splanchnic autonomic outflow in amyloid neuropathy and Tangier disease. Neurology 31 (1981) 461-463
132. Appenzeller O., Kornfeld M., and Snyder R. Acromutilating, paralyzing neuropathy with corneal ulceration in Navajo children. Arch Neurol 33 (1976) 733-738
133. Johnsen S.D., Johnson P.C., and Stein S.R. Familial sensory autonomic neuropathy with arthropathy in Navajo children. Neurology 43 6 (1993) 1120-1125
134. Dyck P.J., Carney J.A., Sizemore G.W., et al. Multiple endocrine neoplasia, type 2b: phenotype recognition; neurological features and their pathological basis. Ann Neurol 6 4 (1979) 302-314
135. Bejaoui K., Wu C., Scheffler M.D., et al. SPTLC1 is mutated in hereditary sensory neuropathy, type 1. Nat Genet 27 3 (2001) 261-262
136. Dawkins J.L., Hulme D.J., Brahmbhatt S.B., et al. Mutations in SPTLC1, encoding serine palmitoyltransferase, long chain base subunit-1, cause hereditary sensory neuropathy type I. Nat Genet 27 3 (2001) 309-312
137. Kok C., Kennerson M.L., Spring P.J., et al. A locus for hereditary sensory neuropathy with cough and gastroesophageal reflux on chromosome 3p22-p24. Am J Hum Genet 73 3 (2003) 632-637
138. Lafreniere R.G., MacDonald M.L., Dube M.P., et al. Identification of a novel gene (HSN2) causing hereditary sensory and autonomic neuropathy type II through the Study of Canadian Genetic Isolates. Am J Hum Genet 74 5 (2004) 1064-1073
139. Maayan C., Kaplan E., Shachar S., et al. Incidence of familial dysautonomia in Israel 1977-1981. Clin Genet 32 2 (1987) 106-108
140. Axelrod F.B. Familial dysautonomia. Muscle Nerve 29 3 (2004) 352-363
141. Blumenfeld A., Slaugenhaupt S.A., Axelrod F.B., et al. Localization of the gene for familial dysautonomia on chromosome 9 and definition of DNA markers for genetic diagnosis. Nat Genet 4 2 (1993) 160-164
142. Slaugenhaupt S.A., Blumenfeld A., Gill S.P., et al. Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia. Am J Hum Genet 68 3 (2001) 598-605
143. Axelrod F.B., Iyer K., Fish I., et al. Progressive sensory loss in familial dysautonomia. Pediatrics 67 4 (1981) 517-522
144. Goebel H.H., Vogel P., and Gabriel M. Neuropathologic and morphometric studies in hereditary motor and sensory neuropathy type II with neurofilament accumulation. Ital J Neurol Sci 7 (1986) 325-332
145. Swanson A.G., Buchan G.C., and Alvord E.C. Anatomic changes in congenital insensitivity to pain: absence of small primary sensory neurons in ganglia, roots and Lissauer's tract. Arch Neurol 12 (1965) 12-24
146. Nolano M., Crisci C., Santoro L., et al. Absent innervation of skin and sweat glands in congenital insensitivity to pain with anhidrosis. Clin Neurophysiol 111 9 (2000) 1596-1601
147. Langer J., Goebel H.H., and Veit S. Eccrine sweat glands are not innervated in hereditary sensory neuropathy type IV: an electron-microscopic study. Acta Neuropathol (Berl) 54 3 (1981) 199-202
148. Indo Y. Genetics of congenital insensitivity to pain with anhidrosis (CIPA) or hereditary sensory and autonomic neuropathy type IV: clinical, biological and molecular aspects of mutations in TRKA(NTRK1) gene encoding the receptor tyrosine kinase for nerve growth factor. Clin Auton Res 12 Suppl 1 (2002) I20-I32
149. Indo Y., Tsuruta M., Hayashida Y., et al. Mutations in the TRKA/NGF receptor gene in patients with congenital insensitivity to pain with anhidrosis. Nat Genet 13 4 (1996) 485-488
150. Low P.A., Burke W.J., and McLeod J.G. Congenital sensory neuropathy with selective loss of small myelinated fibers. Ann Neurol 3 (1978) 179-182
151. Houlden H., King R.H., Hashemi-Nejad A., et al. A novel TRKA (NTRK1) mutation associated with hereditary sensory and autonomic neuropathy type V. Ann Neurol 49 4 (2001) 521-525
152. Brady R.O. Fabry disease. In: Dyck P.J., Thomas P.K., Griffin J.W., et al. (Eds). Peripheral neuropathy (1993), WB Saunders, Philadelphia 1169-1178
153. Ohnishi A., and Dyck P.J. Loss of small peripheral sensory neurons in Fabry disease: histologic and morphometric evaluation of cutaneous nerves, spinal ganglia, and posterior columns. Arch Neurol 31 (1974) 120-127
154. Sima A.A.F., and Robertson D.M. Involvement of peripheral nerve and muscle in Fabry's disease. Ann Neurol 35 (1978) 291-301
155. Kocen R.S., and Thomas P.K. Peripheral nerve involvement in Fabry's disease. Arch Neurol 22 (1970) 81-88
156. Kang W.H., Chun S.I., and Lee S. Generalized anhidrosis associated with Fabry's disease. J Am Acad Derm 17 (1987) 883-887
157. Scott L.J., Griffin J.W., Luciano C., et al. Quantitative analysis of epidermal innervation in Fabry disease. Neurology 52 6 (1999) 1249-1254
158. Cable W.J., Kolodny E.H., and Adams R.D. Fabry disease: impaired autonomic function. Neurology 32 (1982) 498-502
159. Schiffmann R., Hauer P., Freeman B., et al. Enzyme replacement therapy and intraepidermal innervation density in Fabry disease. Muscle Nerve 34 1 (2006) 53-56
160. Schiffmann R., Floeter M.K., Dambrosia J.M., et al. Enzyme replacement therapy improves peripheral nerve and sweat function in Fabry disease. Muscle Nerve 28 6 (2003) 703-710
161. Kimber J., McLean B.N., Prevett M., et al. Allgrove or 4 "A" syndrome: an autosomal recessive syndrome causing multisystem neurological disease. J Neurol Neurosurg Psychiatry 74 5 (2003) 654-657
162. Merson M.H., Hughes J.M., Dowell V.R., et al. Current trends in botulism in the United States. JAMA 229 (1974) 1305-1308
163. Hughes J.M., Blumenthal J.R., Merson M.H., et al. Clinical features of types A and B food-borne botulism. Ann Intern Med 95 (1981) 442-445
164. Koenig M.G., Spickard A., Cardella M.A., et al. Clinical and laboratory observations on type E botulism in man. Medicine 43 (1964) 517-545
165. Koenig M.G., Drutz D.J., Mushlin A.I., et al. Type B botulism in man. Am J Med 42 (1967) 208-219
166. Merz B., Bigalke H., Stoll G., et al. Botulism type B presenting as pure autonomic dysfunction. Clin Auton Res 13 5 (2003) 337-338
167. Jenzer G., Mumenthaler M., Ludin H.P., et al. Autonomic dysfunction in botulism B: a clinical report. Neurology 25 (1975) 150-153
168. Vita G., Girlanda P., Puglisi R.M., et al. Cardiovascular-reflex testing and single-fiber electromyography in botulism: a longitudinal study. Arch Neurol 44 2 (1987) 202-206
169. Freeman R., Roberts M.S., Friedman L.S., et al. Autonomic function and human immunodeficiency virus infection. Neurology 40 4 (1990) 575-580
170. Rüttimann S., Hilti P., Spinas G.A., et al. High frequency of human immunodeficiency virus-associated autonomic neuropathy and more severe involvement in advanced stages of human immunodeficiency virus disease. [see comments]. Arch Intern Med 151 12 (1991) 2441-2443
171. Gastaut J.L., Pouget J., Valentin P., et al. Study of sensory involvement and dysautonomia in HIV infected patients: a prospective study of 55 cases. [in French]. Neurophysiol Clin 22 5 (1992) 417-430
172. Villa A., Foresti V., and Confalonieri F. Autonomic nervous system dysfunction associated with HIV infection in intravenous heroin users. AIDS 6 1 (1992) 85-89
173. Cohen J.A., and Laudenslager M. Autonomic nervous system involvement in patients with human immunodeficiency virus infection. Neurology 39 8 (1989) 1111-1112
174. Schmunis G.A. Trypanosoma cruzi, the etiologic agent of Chagas' disease: status in the blood supply in endemic and nonendemic countries. Transfusion 31 6 (1991) 547-557
175. Meneghelli U.G. Chagas' disease: a model of denervation in the study of digestive tract motility. Braz J Med Biol Res 18 3 (1985) 255-264
176. Dantas R.O., Godoy R.A., Oliveira R.B., et al. Cholinergic innervation of the lower esophageal sphincter in Chagas' disease. Braz J Med Biol Res 20 5 (1987) 527-532
177. Santos S.L., Barcelos I.K., and Mesquita M.A. Total and segmental colonic transit time in constipated patients with Chagas' disease without megaesophagus or megacolon. Braz J Med Biol Res 33 1 (2000) 43-49
178. Neto J.A., Gallo Jr. L., Manco J.C., et al. Postural reflexes in chronic Chagas's heart disease: heart rate and arterial pressure responses. Cardiology 60 6 (1975) 343-357
179. Marin Neto J.A., Gallo Jr. L., Manco J.C., et al. Mechanisms of tachycardia on standing: studies in normal individuals and in chronic Chagas' heart patients. Cardiovasc Res 14 9 (1980) 541-550
180. Amorim D.S., Manco J.C., Gallo Jr. L., et al. Chagas' heart disease as an experimental model for studies of cardiac autonomic function in man. Mayo Clin Proc 57 Suppl (1982) 48-60
181. Sousa A.C., Marin-Neto J.A., Maciel B.C., et al. Cardiac parasympathetic impairment in gastrointestinal Chagas' disease. Lancet 1 8539 (1987) 985
182. Iosa D., Dequattro V., De-Ping Lee D., et al. Pathogenesis of cardiac neuro-myopathy in Chagas' disease and the role of the autonomic nervous system. J Auton Nerv Syst 30 (1990) S83-S88
183. Ribeiro A.L., Moraes R.S., Ribeiro J.P., et al. Parasympathetic dysautonomia precedes left ventricular systolic dysfunction in Chagas disease. Am Heart J 141 2 (2001) 260-265
184. Facer P., Mathur R., Pandya S.S., et al. Correlation of quantitative tests of nerve and target organ dysfunction with skin immunohistology in leprosy. Brain 121 Pt 12 (1998) 2239-2247
185. Shah P.K., Malhotra Y.K., Lakhotia M., et al. Cardiovascular dysautonomia in patients with lepromatous leprosy. Indian J Lepr 62 1 (1990) 91-97
186. McDonald W.I., and Kocen R.S. Diphtheritic neuropathy. In: Dyck P.J., Thomas P.K., Lambert E.H., et al. (Eds). Peripheral neuropathy (1984), WB Saunders, Philadelphia 2010-2017
187. Piradov M.A., Pirogov V.N., Popova L.M., et al. Diphtheritic polyneuropathy: clinical analysis of severe forms. Arch Neurol 58 9 (2001) 1438-1442
188. Idiaquez J. Autonomic dysfunction in diphtheritic neuropathy. J Neurol Neurosurg Psychiatry 55 (1992) 159-161
189. Matikainen E., and Juntunen J. Autonomic nervous system dysfunction in workers exposed to organic solvents. J Neurol Neurosurg Psychiatry 48 10 (1985) 1021-1024
190. Murata K., Araki S., Yokoyama K., et al. Autonomic and peripheral nervous system dysfunction in workers exposed to mixed organic solvents. Int Arch Occup Environ Health 63 5 (1991) 335-340
191. LeQuesne P.M., and McLeod J.G. Peripheral neuropathy following a single exposure to arsenic. J Neurol Sci 32 (1977) 437-451
192. Windebank A.J., McCall J.T., and Dyck P.J. Metal neuropathy. In: Dyck P.J., Thomas P.K., Lambert E.H., et al. (Eds). Peripheral neuropathy (1984), WB Saunders, Philadelphia 2133-2161
193. Murata K., and Araki S. Autonomic nervous system dysfunction in workers exposed to lead, zinc, and copper in relation to peripheral nerve conduction: a study of R-R interval variability. Am J Ind Med 20 5 (1991) 663-671
194. Auld R.B., and Bedwell S.F. Peripheral neuropathy with sympathetic overactivity from industrial contact with acrylamide. Can Med Assoc J 96 (1967) 652-654
195. Nordentoft T., Andersen E.B., and Mogensen P.H. Initial sensorimotor and delayed autonomic neuropathy in acute thallium poisoning. Neurotoxicology 19 3 (1998) 421-426
196. LeWitt P.A. The neurotoxicity of the rat poison vacor: a clinical study of 12 cases. N Engl J Med 302 (1980) 73-77
197. Hancock B.W., and Naysmith A. Vincristine-induced autonomic neuropathy. BMJ 3 (1975) 207
198. Legha S.S. Vincristine neurotoxicity: pathophysiology and management. Med Toxicol 1 6 (1986) 421-427
199. Rosenfeld C.S., and Broder L.E. Cisplatin-induced autonomic neuropathy. Cancer Treat Rep 68 (1984) 659-660
200. Hansen S.W. Autonomic neuropathy after treatment with cisplatin, vinblastine, and bleomycin for germ cell cancer. [see comments]. BMJ 300 (1990) 511-512
201. Richardson P., and Cantwell B.M. Autonomic neuropathy after cisplatin based chemotherapy. [letter; comment]. BMJ 300 (1990) 1466-1467
202. Cohen S.C., and Mollman J.E. Cisplatin-induced gastric paresis. J Neurooncol 5 (1987) 237-240
203. Ekholm E.M., Salminen E.K., Huikuri H.V., et al. Impairment of heart rate variability during paclitaxel therapy. Cancer 88 9 (2000) 2149-2153
204. Ekholm E., Rantanen V., Antila K., et al. Paclitaxel changes sympathetic control of blood pressure. Eur J Cancer 33 9 (1997) 1419-1424
205. Rowinsky E.K., Chaudhry V., Cornblath D.R., et al. Neurotoxicity of taxol. J Natl Cancer Inst Monogr 15 (1993) 107-115
206. Jerian S.M., Sarosy G.A., Link Jr. C.J., et al. Incapacitating autonomic neuropathy precipitated by taxol. Gynecol Oncol 51 2 (1993) 277-280
207. Manolis A.S., Tordjman T., Mack K.D., et al. Atypical pulmonary and neurologic complications of amiodarone in the same patient: report of a case and review of the literature. Arch Intern Med 147 (1987) 1805-1809
208. Fraser D.M., Campbell I.W., and Miller H.C. Peripheral and autonomic neuropathy after treatment with perhexiline maleate. BMJ 2 (1977) 675-676
209. Siddiqui M.A., and Ford P.A. Acute severe autonomic insufficiency during pentamidine therapy. [letter]. South Med J 88 10 (1995) 1087-1088
210. Burnett J.W., Weinrich D., Williamson J.A., et al. Autonomic neurotoxicity of jellyfish and marine animal venoms. Clin Auton Res 8 2 (1998) 125-130
211. Geller R.J., and Benowitz N.L. Orthostatic hypotension in ciguatera fish poisoning. Arch Intern Med 152 10 (1992) 2131-2133
212. Pearn J. Neurology of ciguatera. J Neurol Neurosurg Psychiatry 70 1 (2001) 4-8